| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 04/24/2001 | US6222026 Gcp |
| 04/24/2001 | US6222016 Amino acid sequence of protein involved in chromosome partitioning; drug screening of bacteriostats and bactericides; antibodies |
| 04/24/2001 | US6221913 Dialkyl ureas as calcitonin mimetics |
| 04/24/2001 | US6221909 Administering to the cow the isopropyl ester of the hydroxy analogue of methionine. |
| 04/24/2001 | US6221891 Crystal form of N-(4-triflouromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 04/24/2001 | US6221881 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| 04/24/2001 | US6221879 8-azabicyclo[3.2.1] octane-3-methanamine derivatives as ligands of D2 and D3 dopamine and 5HT1A and 5HT2 serotonin receptors |
| 04/24/2001 | US6221864 Prophylactic or therapeutic agent for diseases attributable to infection with helicobacters |
| 04/24/2001 | US6221856 Inositol derivatives for inhibiting superoxide anion production |
| 04/24/2001 | US6221853 Mixture of pharmaceutically acceptable purified paraffinic hydrocarbons, this vehicle having a melting point of about 37 degrees c.+-4 degrees c. |
| 04/24/2001 | US6221848 In vivo administration to the subject of a polynucleotide encoding a protein that is transiently expressed in said subject; preventing esophagitis during treatment of lung cancer patients with ionizing radiation and/or chemotherapy |
| 04/24/2001 | US6221840 Intestinal trefoil proteins |
| 04/24/2001 | US6221664 Composite vaccine which contains antigen, antibody and recombinant DNA and its preparing method |
| 04/24/2001 | US6221616 Detecting modulators of receptor binding protein; incubate cells with modulators and monitoring reduction in binding activity at receptor |
| 04/24/2001 | US6221613 Utilizing competitive binding to detect preferential modulator activity on receptor binding protein; incubate cells with modulators and monitor binding, detect amplification or reduction of binding to receptors |
| 04/24/2001 | US6221350 Enhancement of microbial colonisation of the gastrointestinal tract |
| 04/24/2001 | CA2053277C Use of lipoxin a4 and its derivatives as antagonists for slow-reacting substances of anaphylaxis |
| 04/24/2001 | CA2046397C Inflammatory bowel disease preventive and curative agents containing zinc l- carnosine salt or complex as active ingredient |
| 04/19/2001 | WO2001027273A1 Human galanin family proteins and polynucleotides encoding the same |
| 04/19/2001 | WO2001027254A2 Gene transfer vectors for treating autoimmune diseases and diseases with immunopathogenesis by therapy |
| 04/19/2001 | WO2001027143A1 Lantibiotic |
| 04/19/2001 | WO2001027140A1 Caspase inhibitors for the treatment and prevention of chemotherapy and radiation therapy induced cell death |
| 04/19/2001 | WO2001027135A2 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 04/19/2001 | WO2001027131A1 Purine derivatives |
| 04/19/2001 | WO2001027130A1 Purine derivatives |
| 04/19/2001 | WO2001027113A2 PYRAZOLO `4,3-d! PYRIMIDINE DERIVATIVES |
| 04/19/2001 | WO2001027104A1 Substituted imidazolidinone derivatives |
| 04/19/2001 | WO2001027102A1 Substituted diazepanes |
| 04/19/2001 | WO2001027101A2 Anhydrous salt |
| 04/19/2001 | WO2001027089A1 Pyrimidine derivatives |
| 04/19/2001 | WO2001027084A1 Beta disubstituted metalloprotease inhibitors |
| 04/19/2001 | WO2001027079A2 Compositions and methods of use of ligands that bind components of the blood coagulation/clotting pathway for the treatment of cancer and angiogenic-based disease |
| 04/19/2001 | WO2001027070A1 Use of carbonylamino derivatives against cns disorders |
| 04/19/2001 | WO2001027068A1 Biaryl ether derivatives useful as monoamine reuptake inhibitors |
| 04/19/2001 | WO2001026737A2 Treatment of excessive bone or cartilage loss with an activator of ror alpha and assay for identifying such activator |
| 04/19/2001 | WO2001026682A2 Modified plant viruses and methods of use thereof |
| 04/19/2001 | WO2001026661A1 Compositions comprising oxophosphonate-based metalloproteinase inhibitors |
| 04/19/2001 | WO2001026659A1 Medicament for treatment of neuropathies |
| 04/19/2001 | WO2001026656A2 5-membered heterocycle derivatives and use thereof as monoamine oxidase inhibitors |
| 04/19/2001 | WO2001026652A1 Fab i inhibitors |
| 04/19/2001 | WO2001026644A2 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 04/19/2001 | WO2001026481A1 Fish feed with increased nucleotide content |
| 04/19/2001 | WO2001014557B1 Pd-1, a receptor for b7-4, and uses therefor |
| 04/19/2001 | WO2001001963A8 A method for the improvement of transport across adaptable semi-permeable barriers |
| 04/19/2001 | WO2000074707A3 Use of interleukin-11 to treat hemorrhagic shock |
| 04/19/2001 | WO2000071138A3 Oral administration of lactobacillus for the maintenance of health in women |
| 04/19/2001 | WO2000068380A3 Extracellular matrix and adhesion-associated proteins |
| 04/19/2001 | WO2000046198A8 Anti-inflammatory indole derivatives |
| 04/19/2001 | WO2000029623A3 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 04/19/2001 | WO2000026245A3 Human membrane transport proteins |
| 04/19/2001 | WO2000012720A9 Elongase genes and uses thereof |
| 04/19/2001 | US20010000345 Compounds such as (4,7-dimethylbenzimidazol-5-yl)guanidine; treating nasal congestion, otitis media, asthma, pain, migraine, gastrointestinal disorder, ulcer |
| 04/19/2001 | DE19945746C1 New Lactobacillus salivarius DSM 12000, for preventing and treating digestive tract infections in ornamental birds and for use as a feed supplement |
| 04/19/2001 | CA2399093A1 Caspase inhibitors for the treatment and prevention of chemotherapy and radiation therapy induced cell death |
| 04/19/2001 | CA2388505A1 5-membered heterocycle derivatives, their preparation and application as medicine |
| 04/19/2001 | CA2387629A1 Modified plant viruses and methods of use thereof |
| 04/19/2001 | CA2387535A1 Substituted imidazolidinone derivatives |
| 04/19/2001 | CA2387314A1 Compositions and methods of use of ligands that bind components of the blood coagulation/clotting pathway for the treatment of cancer and angiogenic-based disease |
| 04/19/2001 | CA2387231A1 Human galanin family proteins and polynucleotides encoding the same |
| 04/19/2001 | CA2387146A1 Gene transfer vectors for treating autoimmune diseases and diseases with immunopathogenesis by therapy |
| 04/19/2001 | CA2386848A1 Compositions comprising oxophosphonate-based metalloproteinase inhibitors |
| 04/19/2001 | CA2386485A1 Beta disubstituted metalloprotease inhibitors |
| 04/19/2001 | CA2382937A1 Anhydrous salt |
| 04/19/2001 | CA2382605A1 Pyrimidine derivatives |
| 04/18/2001 | EP1092765A2 Germination-activated red Ganoderma lucidum spores and method for producing the same |
| 04/18/2001 | EP1092717A2 Polycyclic azaindole derivatives, process for their preparation and pharmaceutical compositions containing them |
| 04/18/2001 | EP1092715A2 Cyano-indole derivatives as inhibitors of serotonin reuptake, method for their preparation and pharmaceutical compositions containing the same |
| 04/18/2001 | EP1092437A1 The use of epidermal growth factor as a gastrointestinal therapeutic agent |
| 04/18/2001 | EP1092433A2 Compositions and methods for treating or preventing inflammatory diseases |
| 04/18/2001 | EP1091957A1 Pyrimidin-aminomethyl-pyridine derivatives, their preparation and their use in the control of helicobacter bacteria |
| 04/18/2001 | EP1091953A1 Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| 04/18/2001 | EP1091943A1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 04/18/2001 | EP1091942A1 Potassium channel blocking agents |
| 04/18/2001 | EP1091763A2 Antiviral and antiretroviral radioimmunomedicaments based on alpha-emitters and beta-emitters |
| 04/18/2001 | EP1091748A2 A pharmaceutical formulation useful for the treatment of hepatitis b, hepatitis c and other viral infections of the liver and a process for its preparation |
| 04/18/2001 | EP1091659A1 Oral form of administration |
| 04/18/2001 | EP0723544B1 ALKOXY ALKYL CARBAMATES OF IMIDAZO[1,2-a]PYRIDINES |
| 04/18/2001 | EP0671923B1 Liver reserve cells |
| 04/18/2001 | CN1292032A Self-regulated apoptosis of inflammatory cells by gene therapy |
| 04/18/2001 | CN1291982A Nitrate salt of anti-ulcer medicine |
| 04/18/2001 | CN1291981A Thiophene nitrone compounds |
| 04/18/2001 | CN1291980A thioether furan nitrone compounds |
| 04/18/2001 | CN1291896A Pharmaceutical compositions for ulcer |
| 04/18/2001 | CN1291890A 20-Hete antagonists and agonists |
| 04/18/2001 | CN1291609A Method of preparing 5-lipoxidase inhibitor possessing different heterocyclic ring system |
| 04/18/2001 | CN1291510A Health-care or medicinal tablet containing active ganoderma extract |
| 04/18/2001 | CN1291505A Medicine for treating gastroenteropathy and its preparing process |
| 04/18/2001 | CN1291504A Medicine for treating cirrhosis ascites |
| 04/18/2001 | CN1291490A Process for preparing medicine 'Bingduxiao' |
| 04/18/2001 | CN1291480A Detoxicating tea for cleaning intestine |
| 04/18/2001 | CN1064710C Therapeutic uses of keratinocyte growth factor |
| 04/18/2001 | CN1064680C Process for preparing magnesium omeprazole |
| 04/18/2001 | CN1064551C Application of salt algae for treating digestive canal disease |
| 04/18/2001 | CN1064544C Chinese medicine powder for treating hepatic disease |
| 04/17/2001 | US6218412 Therapy and prophylaxis of diseases where an increased concentration of interleukin-1.beta. participates in their course, for example septic shock, leukemia, hepatitis, muscular degeneration, degenerative joint diseases |
| 04/17/2001 | US6218397 For therapy of stress-related illnesses, such as stress-induced depression, anxiety, and headache; abdominal bowel syndrome; inflammatory diseases; immune suppression; alzheimer's disease; gastronintestinal diseases |
| 04/17/2001 | US6218389 For therapy and prophylaxis of arthritis, cancer, cardiovascular disorders; skin disorders; ocular disorders; inflammation and gum diseases, multiple sclerosis, cachexia, preventing loosening of prosthetic devices |
| 04/17/2001 | US6218385 1,2,4,5-Tetrahydro-benzo[D]azepin derivatives |
| 04/17/2001 | US6218159 Amino acid sequence; bacteriostats; bactericides; antibiotics; diagnosis of infections; drug screening |
| 04/17/2001 | US6217886 Materials and methods for making improved micelle compositions |